Skip to content

Predicting Outcomes Using Infra-red SEnsors, a Feasibility Study.

Physiological Monitoring in the OR; Predicting Outcomes Using Infra-red SEnsors, a Feasibility Study.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06515080
Acronym
PORPOISE-F
Enrollment
500
Registered
2024-07-23
Start date
2025-03-31
Completion date
2026-07-31
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthetic Drug Adverse Reaction

Keywords

regional oxygen saturation

Brief summary

The aim of this study is to investigate if it is feasible to use a protocol in which avoiding oxygen desaturation in the brain during general anaesthesia can reduce the risk of negative postoperative behavior changes in children. We will recruit children from at least five centres around the world for this feasibility study. Brain oxygenation will be monitored with Near Red Infrascopy (NIRS) which is like a saturation monitor placed on the forehead of the child during anesthesia. The anesthesia is done as per routine, but we will ask the anesthesiologist to record what actions they took when there were signs of decreasing oxygen saturation in the brain. We will also ask the parents to fill in a questionnaire with 27 questions about changes in their child's behavior 7 days after the operation.

Detailed description

This project will investigate the potential effect of a protocol, targeted at counteracting cerebral desaturation during anaesthesia, with the aim of reducing negative post-operative changes in children. Negative post-operative changes (NPOBC) represent a surrogate outcome for neurocognitive damage associated with hemodynamic changes during general anaesthesia. This is a feasibility study that will examine anaesthesia team´s reactions to changes in (1) regional cerebral oxygen saturation (crSO2) (2) systemic hypotension or hypoxaemia, while also reporting any technical issues with data acquisition. We will also estimate the incidence of negative post-operative changes and explore any association with reduced crSO2 in our patient population compared with previous international data. Specifically, this feasibility study will provide data for the robust design and power analysis of a large-scale, randomised interventional trial in children undergoing anaesthesia, with the utilisation of a protocol targeting cerebral oxygen desaturation vs a control group of standard care with no access to crSO2 monitoring. Methods At least 500 children of ages 6 months - 59 months will be recruited from at least 5 centers around the world. Besides routine monitoring, cerebral regional oxygen saturation (crsO2 will be monitored throughout the procedure. Primary outcome The primary outcome is the feasibility of successful data collection of crO2, physiological and PHBQ data in a larger population over multiple international sites. This includes the incidence of technical problems with NIRS monitoring and the parental noncompliance with PHBQ reporting will be determined. Secondary outcomes: * The incidence of reduced crSO2 below baseline (more than 10%) * The area under the curve (AUC) of reduced crSO2 below baseline * The incidence of negative postoperative behaviour changes as determined by the PHBQ administered on day 7 & 30 following surgery. * A set of threshold values for and form of interventions to restore cr02 and/or mean arterial blood pressure (Actions may include any of the following interventions fluid bolus, vasoactive agents, Trendelenburg position, adjustment of anaesthetic dose, and change of ventilation settings) * The incidence of negative post-operative behavioural change and the extent of any association with the AUC of crSO2 below baseline

Interventions

DIAGNOSTIC_TESTNear Red Infrascopy

Monitor of regional cerebral oxygen saturation

Sponsors

The University of Western Australia
CollaboratorOTHER
University of Sao Paulo
CollaboratorOTHER
Universitair Ziekenhuis Brussel
CollaboratorOTHER
Uppsala County Council, Sweden
CollaboratorOTHER_GOV
Istituto Giannina Gaslini
CollaboratorOTHER
Uppsala University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 59 Months
Healthy volunteers
No

Inclusion criteria

* Children scheduled for both elective and non-elective, non-cardiac surgical procedures under general anaesthesia.

Exclusion criteria

* age < 6 months or ≥ 59 months * procedures requiring < 30 minutes of general anaesthesia * imaging procedures * procedures involving neurosurgery, oncology or burns * procedures involving significant pain lasting for more than 1 week on average (e.g. tonsillectomies, major orthopaedic surgery) * other procedures that limit access to the forehead * children that are on supplemental oxygen, are sedated or intubated at the time of inclusion * children with severe developmental delay * procedures with planned postoperative intensive care or hospital stay > 3 days

Design outcomes

Primary

MeasureTime frameDescription
the incidence of technical problems with NIRS monitoring and the parental noncompliance with PHBQ reporting. ChecklistFrom the beginning of the anesthesia until 30 days postoperativelyThe primary outcome is the feasibility

Secondary

MeasureTime frameDescription
CrsO2From immediately before anesthesia induction until a few minutes after extubating up to 10 minutesCerebral regional oxygen saturation monitored with NIRS
Negative postoperative behavior changes (NPOBC)7 to 30 days postoperativelyNegative postoperative behavior changes detected by asking the parents to report changes of behavior assessed with the Post Hospitalization Behavior Questionnaire (PHBQ) at day 7 and day 30 postop

Countries

Australia, Belgium, Brazil, Italy, Sweden

Contacts

Primary ContactPeter Frykholm, M.D., Ph.D.
peter.frykholm@uu.se+46186171240
Backup ContactAli-Reza Modiri, Ph.D.
ali-reza.modiri@uu.se+46186110000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026